Почетна › Миелодиспластични синдроми › Мериленд
Клинички испитувања за Миелодиспластични синдроми во Мериленд
23 студии за Миелодиспластични синдроми бараат учесници на локации во Мериленд.
Градови во Мериленд
Официјален текст на студијата (англиски)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- Walter Reed National Military Medical Center, Bethesda
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT05564390Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Се регрутираРана фаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06398457Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Walter Reed National Military Medical Center, Bethesda
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06577441Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
- National Institutes of Health Clinical Center, Bethesda
Се регрутираНабљудувачка студија
1 Day – 99 Years · Сите полови · Ажурирано 5.10.2026 · NCT07683104Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 1
Возраст од 18 до 120 · Сите полови · Ажурирано 5.10.2026 · NCT06904066Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 1/2
Возраст од 12 до 120 · Сите полови · Ажурирано 5.10.2026 · NCT06303193Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 1/2
Возраст од 4 до 75 · Сите полови · Ажурирано 1.10.2026 · NCT03173937Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06484062CHIP/CCUS Natural History Protocol
- National Institutes of Health Clinical Center, Bethesda
Се регрутираНабљудувачка студија
Возраст од 18 до 99 · Сите полови · Ажурирано 28.9.2026 · NCT04102423Natural History Study of GATA2 Deficiency and Related Disorders
- National Institutes of Health Clinical Center, Bethesda
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 2 до 100 · Сите полови · Ажурирано 22.9.2026 · NCT01905826Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 2
Возраст од 4 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT01174108Collection of Tissue Samples for Cancer Research
- Johns Hopkins University, Baltimore
- National Institutes of Health Clinical Center, Bethesda
Се регрутираНабљудувачка студија
2 Months · Сите полови · Ажурирано 16.9.2026 · NCT00900198The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Се регрутираФаза 1/2
До возраст 22 · Сите полови · Ажурирано 25.8.2026 · NCT04726241A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
- Maryland Oncology Hematolofy, Columbia
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 21.8.2026 · NCT06499285A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
- The Center for Cancer and Blood Disorders (CCBD) - Bethesda, Bethesda
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 21.8.2026 · NCT04419649Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
- National Institutes of Health Clinical Center, Bethesda
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
1 Day – 120 Years · Сите полови · Ажурирано 23.7.2026 · NCT05350748Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
- National Institutes of Health Clinical Center, Bethesda
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 18 до 120 · Сите полови · Ажурирано 23.7.2026 · NCT05588154A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
- National Institutes of Health Clinical Center, Bethesda
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 10.7.2026 · NCT05027945Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
- National Institutes of Health Clinical Center, Bethesda
Се регрутираНабљудувачка студија
1 Month – 120 Years · Сите полови · Ажурирано 6.7.2026 · NCT07019155Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Се регрутираРана фаза 1
Возраст од 18 до 100 · Сите полови · Ажурирано 27.3.2026 · NCT07071155A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Sibley Memorial Hospital, Baltimore
- University of Maryland, Baltimore
- Johns Hopkins Main Center, Baltimore
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 24.3.2026 · NCT04988555Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 23.12.2025 · NCT04245397SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- и уште 1
Се регрутираНабљудувачка студија
Сите возрасти · Сите полови · Ажурирано 28.10.2025 · NCT03452774Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.